• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Pediatric Ophthalmology  • Retinal/ Chorioretinal Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Dordi Austeng, MD; Karin B. M. Källen, PhD; Uwe W. Ewald, MD, PhD; Peter G. Jakobsson, MD, PhD; Gerd E. Holmström, MD, PhD

Arch Ophthalmol. 2009;127(10):1315-1319.

Objective  To determine the incidence of retinopathy of prematurity (ROP) in extremely preterm infants born before 27 weeks' gestation in Sweden during a 3-year period.

Methods  A national, prospective, population-based study was performed in Sweden from April 1, 2004, to March 31, 2007. The ophthalmologic part of the study was separately organized, and screening for ROP was performed beginning postnatal week 5. The criteria for the treatment of ROP agreed with the recommendations of the Early Treatment for Retinopathy of Prematurity Cooperative Group.

Results  During the study, 506 of 707 live-born infants survived until the first eye examination. Of these, 368 (72.7%) had ROP: 37.9% had mild ROP and 34.8% had severe ROP. Ninety-nine infants (19.6%) were treated. Gestational age at birth was a stronger predictor of ROP than was birth weight. A log-linear relationship between severe ROP and gestational age at birth was found in the present cohort, and the risk of ROP was reduced by 50% for each week of increase in gestational age at birth.

Conclusions  Today, extremely preterm infants are surviving, and this population-based study with ROP as a primary outcome shows a higher incidence of this condition than in previously reported national cohorts.

Author Affiliations: Departments of Ophthalmology (Drs Austeng and Holmström) and Women's and Children's Health (Dr Ewald), University Hospital, Uppsala; Tornbladsinstitutet, University of Lund, Lund (Dr Källen); and University of Linköping, Linköping (Dr Jakobsson), Sweden; and Department of Ophthalmology, Trondheim University Hospital, Trondheim, Norway (Dr Austeng).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

No advanced retinopathy of prematurity stages 4 or 5 in a large high-risk German cohort
Muether et al.
Br J Ophthalmol 2011;0:bjo.2011.203125v1-bjo.2011.203125.
ABSTRACT | FULL TEXT  

Screening for Retinopathy of Prematurity in Infants Born Before 27 Weeks' Gestation in Sweden
Austeng et al.
Arch Ophthalmol 2011;129:167-172.
ABSTRACT | FULL TEXT  

Natural History of Retinopathy of Prematurity in Infants Born Before 27 Weeks' Gestation in Sweden
Austeng et al.
Arch Ophthalmol 2010;128:1289-1294.
ABSTRACT | FULL TEXT  

Treatment for retinopathy of prematurity in infants born before 27 weeks of gestation in Sweden
Austeng et al.
Br J Ophthalmol 2010;94:1136-1139.
ABSTRACT | FULL TEXT